Dow Down 0.48% Nasdaq Up 0.29%

Flexion Therapeutics, Inc. (FLXN)

-NasdaqGM
17.44 Up 1.91(12.30%) May 31, 4:00PM EDT
Prev Close:15.53
Open:15.66
Bid:17.00 x 100
Ask:19.91 x 100
1y Target Est:36.50
Beta:N/A
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:15.39 - 17.87
52wk Range:7.56 - 29.09
Volume:827,956
Avg Vol (3m):271,905
Market Cap:376.19M
P/E (ttm):N/A
EPS (ttm):-2.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for FLXN

Comparison

Symbol% ChgMkt Cap
FLXNUp 12.30%376.19M
JNJDown 0.33%309.97B
PCRXUp 2.09%1.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.98
Quarterly EPS Est (Jun-16) :-0.72
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback